Pain Therapeutics’ opioid drug fails to gain FDA approval
Regulator waiting for non-opioid alternatives to reach the market
Declaration means potential more resources and power to states and federal agencies.
Pharma makes decision after FDA intervenes to fight opioid crisis.
Companies hope tanezumab offers alternative to opioids
Regulator concerned about potential abuse of Opana ER
Watson will be used to improve prevention of Substance Use Disorder relapses.
Amid opiate crisis, Purdue looks for abuse-deterrent alternatives.